Status:
COMPLETED
Study Comparing Premarin® Vaginal Cream Versus Premarin® Oral Tablets in Atrophic Vaginitis
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Conditions:
Atrophic Vaginitis
Eligibility:
FEMALE
45-80 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to characterize the systemic exposure and bioavailability at steady state of Premarin® Vaginal Cream compared with Premarin® oral tablets in postmenopausal women with atro...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Generally healthy postmenopausal women.
- Intact uterus.
- Clinical diagnosis of moderate to severe atrophic vaginitis.
Exclusion
Key Trial Info
Start Date :
October 1 2005
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT00167921
Start Date
October 1 2005
Last Update
May 28 2007
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Miami, Florida, United States, 33136
2
Baltimore, Maryland, United States, 21225